Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.tem.2015.01.002 http://scihub22266oqcxt.onion/10.1016/j.tem.2015.01.002 C4718075!4718075!25656826     free     free     free       Trends+Endocrinol+Metab 2015 ; 26 (3): 153-61 Nephropedia Template TP {{tp|p=25656826|t=2015. Adipocytokines and Hepatic Fibrosis |pdf=|usr=}}{{25656826}} gab.com Text Adipocytokines and Hepatic Fibrosis JO: Trends Endocrinol Metab http://www.kidney.de/pget.php?&tw=1&pmid=25656826 #FOAvip Obesity and metabolic syndrome pose significant risk for progression of many types of chronic illnesses, including liver disease. Hormones released from adipocytes, adipocytokines, associated with obesity and metabolic syndrome, have been shown to control hepatic inflammation and fibrosis. Hepatic fibrosis is the final common pathway that can result in cirrhosis, and can ultimately require liver transplantation. Initially, two key adipocytokines, leptin and adiponectin, appeared to control many fundamental aspects of the cell and molecular biology related to hepatic fibrosis and its resolution. Leptin appears to act as a profibrogenic molecule while adiponectin possesses strong-anti-fibrotic properties. In this review, we emphasize pertinent data associated with these, and recently discovered, adipocytokines that may drive or halt the fibrogenic response in the liver. Twit Text FOAVip Adipocytokines and Hepatic Fibrosis ????Trends Endocrinol Metab http://www.kidney.de/pget.php?&tw=1&pmid=25656826 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25656826 #FOAvip English Wikipedia <ref>{{Cite pmid|25656826}}</ref> Adipocytokines and Hepatic Fibrosis #MMPMID25656826 Saxena NK; Anania FA Trends Endocrinol Metab 2015[Mar]; 26 (3): 153-61 PMID25656826show ga Obesity and metabolic syndrome pose significant risk for progression of many types of chronic illnesses, including liver disease. Hormones released from adipocytes, adipocytokines, associated with obesity and metabolic syndrome, have been shown to control hepatic inflammation and fibrosis. Hepatic fibrosis is the final common pathway that can result in cirrhosis, and can ultimately require liver transplantation. Initially, two key adipocytokines, leptin and adiponectin, appeared to control many fundamental aspects of the cell and molecular biology related to hepatic fibrosis and its resolution. Leptin appears to act as a profibrogenic molecule while adiponectin possesses strong-anti-fibrotic properties. In this review, we emphasize pertinent data associated with these, and recently discovered, adipocytokines that may drive or halt the fibrogenic response in the liver. äAdipocytokines and Hepatic Fibrosis (epmc).pdf DeepDyve Pubget Overpricing